Does TACROLIMUS Cause Therapeutic product effect incomplete? 292 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 292 reports of Therapeutic product effect incomplete have been filed in association with TACROLIMUS (Tacrolimus). This represents 0.3% of all adverse event reports for TACROLIMUS.
292
Reports of Therapeutic product effect incomplete with TACROLIMUS
0.3%
of all TACROLIMUS reports
20
Deaths
62
Hospitalizations
How Dangerous Is Therapeutic product effect incomplete From TACROLIMUS?
Of the 292 reports, 20 (6.8%) resulted in death, 62 (21.2%) required hospitalization, and 12 (4.1%) were considered life-threatening.
Is Therapeutic product effect incomplete Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TACROLIMUS. However, 292 reports have been filed with the FAERS database.
What Other Side Effects Does TACROLIMUS Cause?
Off label use (8,718)
Drug ineffective (6,214)
Product use in unapproved indication (5,057)
Acute kidney injury (4,005)
Transplant rejection (3,526)
Cytomegalovirus infection (3,320)
Covid-19 (3,201)
Drug interaction (2,896)
Diarrhoea (2,854)
Toxicity to various agents (2,845)
What Other Drugs Cause Therapeutic product effect incomplete?
ALBUTEROL (8,496)
ADALIMUMAB (6,986)
PREDNISONE (6,709)
METHOTREXATE (6,037)
TOFACITINIB (4,914)
SECUKINUMAB (4,661)
BUDESONIDE\FORMOTEROL (4,392)
TIOTROPIUM (4,327)
MEPOLIZUMAB (4,106)
ETANERCEPT (3,961)
Which TACROLIMUS Alternatives Have Lower Therapeutic product effect incomplete Risk?
TACROLIMUS vs TACROLIMUS\TACROLIMUS ANHYDROUS
TACROLIMUS vs TADALAFIL
TACROLIMUS vs TAFAMIDIS
TACROLIMUS vs TAFAMIDIS MEGLUMINE
TACROLIMUS vs TAFASITAMAB